Vol 72, No 1 (2021)

Date published: 2021-02-26

Table of Contents

open access

Letter to Readers [List do Czytelników]

Beata Kos-Kudła

Letter to Readers

Endokrynol Pol 2021;72(1):1-2.
Original Paper

Titin and dystrophin serum concentration changes in patients affected by thyroid disorders

Ariadna Zybek-Kocik, Nadia Sawicka-Gutaj, Remigiusz Domin, Ewelina Szczepanek-Parulska, Tomasz Krauze, Przemysław Guzik, Marek Ruchała

Original paper

Pubmed: 33295636
Endokrynol Pol 2021;72(1):1-7.

Free triiodothyronine/free thyroxine (FT3/FT4) ratio is strongly associated with insulin resistance in euthyroid and hypothyroid adults: a cross-sectional study

Ladislav Štěpánek, Dagmar Horáková, Lubomír Štěpánek, Vladimír Janout, Jana Janoutová, Kateřina Bouchalová, Karel Martiník

Original paper

Pubmed: 33125689
Endokrynol Pol 2021;72(1):8-13.

miR-597-3p inhibits invasion and migration of thyroid carcinoma SW579 cells by targeting RAB23

Hu-Ling Wen, Zheng-Min Xu, Shi-Yu Lin, Dan Wen, Jian Ping Xie

Original paper

Pubmed: 32856288
Endokrynol Pol 2021;72(1):22-28.

Aberrant expression of semaphorin 6B affects cell phenotypes in thyroid carcinoma by activating the Notch signalling pathway

Xiu-Juan Lv, Xin Chen, Yan Wang, Shan Yu, Lin Pang, Chao Huang

Original paper

Pubmed: 33125690
Endokrynol Pol 2021;72(1):29-36.

Flow cytometric DNA analysis of parathyroid benign lesions

Agata Gawrychowska, Grzegorz Kowalski, Małgorzata Nabrdalik, Grzegorz Buła, Bożena Lackowska, Adam Bednarczyk, Marcin Werbowski, Joanna Polczyk, Jacek Gawrychowski

Original paper

Pubmed: 33125694
Endokrynol Pol 2021;72(1):44-50.
Short communication

Amino acids profile in girls with Turner syndrome during growth hormone therapy

Jolanta Bugajska, Joanna Berska, Małgorzata Wójcik, Jerzy B. Starzyk, Krystyna Sztefko

Brief communication

Pubmed: 33619714
Endokrynol Pol 2021;72(1):51-52.
Review Article

Pituitary transcription factors in the immunohistochemical and molecular diagnosis of pituitary tumours — a systematic review

Iulia Florentina Burcea, Valeria-Nicoleta Năstase, Cătălina Poiană

Review paper

Pubmed: 33749818
Endokrynol Pol 2021;72(1):53-63.

Cushing's syndrome in pregnancy: a review of reported cases

Georgios Kyriakos, Paraskevi Farmaki, Errika Voutyritsa, Alexandros Patsouras, Lourdes Victoria Quiles-Sánchez, Christos Damaskos, Athanasia Stelianidi, Adrián Pastor-Alcaraz, Patricia Palomero-Entrenas, Evangelos Diamantis

Review paper

Pubmed: 33749819
Endokrynol Pol 2021;72(1):64-72.

Expression of miRNA in obesity and insulin resistance: a review

Paulina Estrella Ibarra, Pablo García-Solís, Juan Carlos Solís-Sáinz, Andrés Cruz-Hernández

Review paper

Pubmed: 33749820
Endokrynol Pol 2021;72(1):73-80.
Clinical Vignette

A combination of plasma exchange and steroids in the treatment of a-lipoic acid-induced insulin autoimmune syndrome

Xiao Sheng, Xinhua Ye, Xiaoqi Shi, Lin Lu, Aijiao Lu, Yun Xue, Yunfeng Du, Jinluo Cheng

Clinical vignette

Pubmed: 33295634
Endokrynol Pol 2021;72(1):81-82.

SIADH in the context of localised Herpes-Zoster infection

Catarina Cidade-Rodrigues, Adriana Silva, Fátima Costa, Catarina Couto, Filipe Esteves, Ana João Sá, Inês Ferreira

Clinical vignette

Pubmed: 33295633
Endokrynol Pol 2021;72(1):83-84.

Resistance to thyroid hormone caused by a mutation of the thyroid β receptor gene in a family over three generations

Liping Chen, Lin Ding, Xinlong Chen, Xiaoqian Zhang

Clinical vignette

Pubmed: 33619717
Endokrynol Pol 2021;72(1):85-86.

Adjuvant therapy in type 1 diabetes mellitus

Edyta Cichocka, Anna Maj-Podsiadło, Janusz Gumprecht

Clinical vignette

Pubmed: 33619718
Endokrynol Pol 2021;72(1):87-88.



Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl